• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单剂量低抗原无细胞百日咳疫苗在未接种疫苗青少年人群中的免疫原性。

Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population.

作者信息

Knuf Markus, Zepp Fred, Meyer Claudius, Grzegowski Edith, Wolter Joanne, Riffelmann Marion, Wirsing von König Carl Heinz

机构信息

Department of Pediatrics, Johannes Gutenberg University of Mainz, Germany.

出版信息

Vaccine. 2006 Mar 15;24(12):2043-8. doi: 10.1016/j.vaccine.2005.11.024. Epub 2005 Nov 28.

DOI:10.1016/j.vaccine.2005.11.024
PMID:16356597
Abstract

German adolescents (n=123) without previous pertussis vaccination, no history of pertussis and low IgG-anti-pertussis-toxin (PT) levels received one dose of the Tdap vaccine Boostrix. Blood samples were taken before, and 5-12 days and 29-49 days after vaccination. IgG- and IgA-anti-PT, IgG- and IgA-anti filamentous hemagglutinin, IgG-anti-pertactin, IgG-anti-tetanus-toxin, and IgG-anti-diphtheria-toxin were measured by ELISA. 88.6% of subjects had an immune response to PT, and all vaccinees had an immune response to at least one pertussis antigen 29-49 days after vaccination. IgA-anti-PT and IgA-anti-FHA responses were found in 43 and 81% of subjects, respectively. This study shows that in unvaccinated German adolescents pertussis immunity can be achieved by a single dose of Tdap.

摘要

123名未曾接种过百日咳疫苗、无百日咳病史且抗百日咳毒素(PT)的IgG水平较低的德国青少年接种了一剂吸附无细胞百白破疫苗(Tdap)“保适博”。在接种前、接种后5 - 12天以及29 - 49天采集血样。通过酶联免疫吸附测定法(ELISA)检测抗PT的IgG和IgA、抗丝状血凝素的IgG和IgA、抗百日咳杆菌黏附素的IgG、抗破伤风毒素的IgG以及抗白喉毒素的IgG。88.6%的受试者对PT产生了免疫反应,并且所有接种者在接种后29 - 49天对至少一种百日咳抗原产生了免疫反应。分别在43%和81%的受试者中发现了抗PT的IgA和抗丝状血凝素(FHA)的IgA反应。这项研究表明,在未接种疫苗的德国青少年中,一剂Tdap疫苗可实现百日咳免疫。

相似文献

1
Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population.单剂量低抗原无细胞百日咳疫苗在未接种疫苗青少年人群中的免疫原性。
Vaccine. 2006 Mar 15;24(12):2043-8. doi: 10.1016/j.vaccine.2005.11.024. Epub 2005 Nov 28.
2
Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.在小鼠模型中对一种新型低剂量破伤风白喉无细胞百日咳疫苗针对百日咳博德特氏菌的安全性和有效性评估。
BMC Infect Dis. 2017 Apr 4;17(1):247. doi: 10.1186/s12879-017-2369-x.
3
Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.婴儿期接种的三组分无细胞百日咳疫苗在生命最初6年的持续效力:意大利的经验。
Pediatrics. 2001 Nov;108(5):E81. doi: 10.1542/peds.108.5.e81.
4
IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.荷兰4岁儿童接种不同百日咳疫苗加强针后的IgG反应:疫苗抗原含量的影响。
Vaccine. 2009 Nov 5;27(47):6530-6. doi: 10.1016/j.vaccine.2009.08.052. Epub 2009 Sep 1.
5
Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.抗原含量降低的破伤风-白喉-无细胞百日咳疫苗作为含无细胞百日咳疫苗的第六剂在青少年中的免疫原性。
Vaccine. 2007 Jul 20;25(29):5248-52. doi: 10.1016/j.vaccine.2007.05.012. Epub 2007 Jun 4.
6
Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.未接种疫苗和已接种疫苗的百日咳患儿及成人针对百日咳毒素和丝状血凝素的血清IgG抗体反应。
Clin Infect Dis. 1999 Mar;28(3):552-9. doi: 10.1086/515172.
7
Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults.一种破伤风、白喉、重组无细胞百日咳联合疫苗(TdaP)在泰国健康成年人中的安全性和免疫原性。
Hum Vaccin Immunother. 2017 Jan 2;13(1):136-143. doi: 10.1080/21645515.2016.1234555. Epub 2016 Sep 29.
8
Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.低抗原含量破伤风-白喉-无细胞百日咳疫苗作为第六剂含无细胞百日咳疫苗在青少年中的安全性。
J Pediatr. 2006 Nov;149(5):603-610. doi: 10.1016/j.jpeds.2006.06.016.
9
Assessing the reactogenicity of Tdap vaccine administered during pregnancy and antibodies to Bordetella pertussis antigens in maternal and cord sera of Thai women.评估在泰国孕妇孕期接种 Tdap 疫苗的反应原性和母血及脐血中百日咳鲍特菌抗原抗体。
Vaccine. 2018 Mar 7;36(11):1453-1459. doi: 10.1016/j.vaccine.2018.01.059.
10
Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.青少年百日咳的预防:破伤风类毒素、白喉类毒素减少量及无细胞百日咳(Tdap)疫苗的使用建议
Pediatrics. 2006 Mar;117(3):965-78. doi: 10.1542/peds.2005-3038. Epub 2005 Dec 28.

引用本文的文献

1
ERRATA CORRIGE.勘误表
J Prev Med Hyg. 2021 Apr 29;62(1):E249-E260. doi: 10.15167/2421-4248/jpmh2021.62.1.1832. eCollection 2021 Mar.
2
Immunogenicity and antibody persistence of diphteria-tetanus-acellular pertussis vaccination in adolescents and adults: a systematic review of the literature showed different responses to the available vaccines.青少年和成人中白喉-破伤风-无细胞百日咳疫苗的免疫原性和抗体持久性:一项文献系统综述显示,对现有疫苗的反应各异。
J Prev Med Hyg. 2021 Jan 14;61(4):E530-E541. doi: 10.15167/2421-4248/jpmh2020.61.4.1832. eCollection 2020 Dec.
3
Pertussis: Microbiology, Disease, Treatment, and Prevention.
百日咳:微生物学、疾病、治疗与预防
Clin Microbiol Rev. 2016 Jul;29(3):449-86. doi: 10.1128/CMR.00083-15.
4
Evaluation of a new syringe presentation of reduced-antigen content diphtheria, tetanus, and acellular pertussis vaccine in healthy adolescents--A single blind randomized trial.健康青少年中低抗原含量白喉、破伤风和无细胞百日咳疫苗新型注射器剂型的评估——一项单盲随机试验。
Hum Vaccin Immunother. 2015;11(7):1770-4. doi: 10.1080/21645515.2015.1041697.
5
Toward a new vaccine for pertussis.迈向百日咳疫苗的新征程。
Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3213-6. doi: 10.1073/pnas.1324149111. Epub 2014 Feb 20.
6
Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.吸附无细胞百白破灭活、全细胞百日咳和破伤风联合疫苗(Boostrix®):作为单剂加强免疫的特性和用途介绍。
Drugs. 2012 Sep 10;72(13):1765-91. doi: 10.2165/11209630-000000000-00000.
7
Serum IgA responses against pertussis proteins in infected and Dutch wP or aP vaccinated children: an additional role in pertussis diagnostics.感染及荷兰全细胞百日咳疫苗或无细胞百日咳疫苗接种儿童血清 IgA 对百日咳蛋白的应答:在百日咳诊断中的额外作用。
PLoS One. 2011;6(11):e27681. doi: 10.1371/journal.pone.0027681. Epub 2011 Nov 14.
8
Immunization of teenagers with a fifth dose of reduced DTaP-IPV induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activity.用第五剂减量白喉破伤风无细胞百白破-灭活脊髓灰质炎疫苗对青少年进行免疫接种可诱导产生高水平的百日咳抗体,且调理吞噬活性显著增加。
Clin Vaccine Immunol. 2011 Aug;18(8):1269-74. doi: 10.1128/CVI.05067-11. Epub 2011 Jun 15.
9
[Vaccination in adults].[成人疫苗接种]
Internist (Berl). 2011 Mar;52(3):239-49. doi: 10.1007/s00108-010-2677-3.
10
Pertussis serology: assessment of IgG anti-PT ELISA for replacement of the CHO cell assay.百日咳血清学:IgG 抗-PT ELISA 替代 CHO 细胞检测法的评估。
APMIS. 2010 Dec;118(12):968-72. doi: 10.1111/j.1600-0463.2010.02664.x. Epub 2010 Sep 2.